Research Article

Prevalence and pattern of congenital heart disease among children with Down syndrome seen in a Federal Medical Centre in the Niger Delta Region, Nigeria

Ujuanbi Amenawon Susan* and Onyeka Adaeze Chiemerie

Published: 11 April, 2022 | Volume 7 - Issue 1 | Pages: 030-035

Background: Down syndrome (DS), or Trisomy 21, is the most common genetic disorder in the world and congenital heart disease (CHD) contributes significantly to morbidity and mortality in this population. Early diagnosis and prompt cardiac intervention improve their quality of life. This study was done to determine the prevalence and pattern of congenital heart disease among children with Down syndrome seen at the Paediatric Cardiology Unit of Federal Medical Centre (FMC), Bayelsa State.
Method: A prospective study of children with Down syndrome referred for cardiac evaluation and echocardiography at the Paediatric Cardiology Unit of FMC, Bayelsa State over four years from 1st January 2016 to 30th December 2019. Data on socio-demographic information, echocardiographic diagnosis, and outcome were retrieved from the study proforma and analyzed.
Results: A total of 24 children with Down syndrome were seen over the study period. Their age ranged from 0 to 16years. The majority, 20 (83.3%) of the children with Down syndrome were aged 5 years and below. There were 13 males and 11 females with a male to female ratio of 1.2:1. A total of 23 (95.8%) of the children with Down syndrome had CHD. The most common CHD was AVSD (including complete, partial, isolated, or in association with other defects) in 66.6% followed by TOF in 8.3%. Multiple CHDs were seen in 43.5% of the children. Only one child (4.2%) had a structurally normal heart on echocardiography. All the children with Down syndrome had pericardial effusion of varying severity while 33% had pulmonary artery hypertension (PAH). The fatality rate among the children seen with Down syndrome over the study period was 34.8% and only one child (4.2%) had open-heart surgery with the total repair of cardiac defect during the study period. 
Conclusion: Morbidity and mortality are high among children with Down syndrome due to the high prevalence of CHD. Early referral, diagnosis, and prompt intervention are encouraged.

Read Full Article HTML DOI: 10.29328/journal.jccm.1001129 Cite this Article Read Full Article PDF


Down syndrome; Prevalence; Pattern; Congenital heart disease; Niger delta; Nigeria


  1. Spicer RL. Cardiovascular disease in Down syndrome. Pediatr Clin North Am. 1984; 31: 1331-1343. PubMed: https://pubmed.ncbi.nlm.nih.gov/6239137/
  2. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am College Cardiol. 2002; 39: 1890–900. PubMed: https://pubmed.ncbi.nlm.nih.gov/12084585/
  3. Lacro RV. Dysmorphology and genetics. In: Keane JF, Lock JE, Fyler DC, editors. Nadas′ Pediatric Cardiology. UK: Elsevier; 2007: 49-72.
  4. Asani M, Aliyu I, Also U. Pattern of congenital heart diseases among children with Down syndrome seen in Aminu Kano Teaching Hospital, Kano, Nigeria. Niger J Basic Clin Sci. 2013; 10: 57-59.
  5. Ko JM. Genetic syndromes associated with congenital heart disease. Korean Circ J. 2015; 45: 357-361. PubMed: https://pubmed.ncbi.nlm.nih.gov/26413101/
  6. Freeman SB, Taft LF, Dookey KJ, Allran K, Sherman SL, et al. Population based study of congenital heart disease in Down syndrome. Am J Med Genet. 1998; 80: 213-217. PubMed: https://pubmed.ncbi.nlm.nih.gov/9843040/
  7. Wells GL, Baker SE, Finley SC, Colvin EV, Finley WH. Congenital heart disease in infants with Down syndrome. South Med J 1994; 87: 724-727. PubMed: https://pubmed.ncbi.nlm.nih.gov/8023205/  
  8. Cleves MA, Hobbs CA, Cleves PA, Tilford JM, Bird TM, et al. Congenital defects among live born infants with Down syndrome. Birth Defects Res A Clin Mol Teratol. 2007; 79: 657-663. PubMed: https://pubmed.ncbi.nlm.nih.gov/17696161/
  9. Ekure EN, Animashaun A, Bastos M, Ezeaka VC. Congenital heart disease associated with identified syndromes and other extra cardiac congenital malformations in children in Lagos. West Afr J Med. 2009; 28: 33-37. PubMed: https://pubmed.ncbi.nlm.nih.gov/19662743/
  10. Okeniyi JA, Onakpoya UU, Samuel I, Adegoke OT, Okolugbo J. Spectrum of congenital heart disease in children with Down syndrome in Ile-Ife Nigeria. Curr Paediatr Res. 2017; 21: 410-415.
  11. Sadoh WE, EKI-Udoko FE, Isah IA. Profile of clinical features, congenital heart disease and other comorbidities in children with Down syndrome in a tertiary care centre in Nigeria. Sri Lanka J Child Health. 2018; 47: 50-55.
  12. Otaigbe BE, Tabansi PN, Agbedeyi GO. Pattern of congenital heart defects in children with down syndrome at the University of Port Harcourt Teaching Hospital, Port Harcourt. Niger J Paed. 2012; 39: 164-167.
  13. Concolino D, Pascuzzi A, Pietragalla E, Lia R, Canepa S, et al. High prevalence of isolated pericardial effusion in down syndrome. Am J Med Genet A. 2005; 132A: 331-332. PubMed: https://pubmed.ncbi.nlm.nih.gov/15523613/
  14. Oyedeji GA. Socio-economic and cultural background of hospitalized children in Ilesha. Nig J Pediatr 1985; 12: 111-117.
  15. El-Gilany AH, Yahia S, Wahba Y. Prevalence of congenital heart diseases in children with Down syndrome in Mansoura, Egypt: a retrospective descriptive study. Ann Saudi Med. 2017; 37: 386-392. PubMed: https://pubmed.ncbi.nlm.nih.gov/28988253/
  16. Benhaourech S, Drighil A, El Hammiri A. Congenital heart disease and Down syndrome: various aspects of a confirmed association. Cardiovasc J Afr. 2016; 27: 287–290. PubMed: https://pubmed.ncbi.nlm.nih.gov/27805241/
  17. Boussouf K, Zoubida Z, Mounira A, Naima H, Malika M, et al. Study of congenital heart diseases in patients with Down syndrome in Algeria. East Mediterr Health J. 2017; 23: 632-636..
  18. Torfs CP, Christianson RE. Anomalies in Down syndrome individuals in a large population-based registry. Am J Med Genet. 1998; 77: 431-438. PubMed: https://pubmed.ncbi.nlm.nih.gov/9632176/
  19. Jou HJ, Kuo YS, Hsu JJ, Shyu MK, Hsieh TT et al. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second trimester maternal serum screening. Prenat Diagn. 2005;: 665–670. PubMed: https://pubmed.ncbi.nlm.nih.gov/16049991/
  20. Agathokleous M, Chaveeva P, Poon LC, Kosinski P, Nicolaides KH. Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet Gynecol. 2013; 41: 247-461. PubMed: https://pubmed.ncbi.nlm.nih.gov/23208748/
  21. Geelhoed EA, Bebbington A, Bower C, Deshpande A, Leonard H. Direct health care costs of children and adolescents with Down syndrome. J Pediatr. 2011; 159: 541-545. PubMed: https://pubmed.ncbi.nlm.nih.gov/21784457/
  22. Bertelli ECP, Biselli JM, Bonfim D, Goloni-Bertollo EM. Clinical profile of children with Down syndrome treated in a genetics outpatient service in the Southeast of Brazil. Rev Assoc Med Bras. 2009; 55: 547–552. PubMed: https://pubmed.ncbi.nlm.nih.gov/19918654/
  23. Nisli K, Candan SKH, Tansel TTE, Karaman B, Omeroglu RE, et al. Congenital heart disease in children with Down's syndrome: Turkish experience of 13 years. Acta Cardiol.2008; 63: 585-589. PubMed: https://pubmed.ncbi.nlm.nih.gov/19014001/   
  24. de Rubens Figueroa J, del Pozzo Magaña B, Pablos Hach JL, Calderón Jiménez C, Castrejón Urbina R. Heart malformations in children with Down syndrome. Rev Esp Cardiol.2003; 56: 894-899. PubMed: https://pubmed.ncbi.nlm.nih.gov/14519277/  
  25. Ferencz CH, Neill C, Boughman J, Rubin J, Brenner J, et al. Congenital cardiovascular malformations associated with chromosome abnormalities: an epidemiologic study. J Pediatr. 1989; 114: 79-86. PubMed: https://pubmed.ncbi.nlm.nih.gov/2521249/
  26. Hayes C, Johnson Z, Thornton L, Fogarty J, Lyons R, et al. Ten year survival of Down syndrome births. Int J Epidemiol. 1997; 4: 822-821. PubMed: https://pubmed.ncbi.nlm.nih.gov/9279615/
  27. Maroto CM, Enríquez de Salamanca F, Herráiz IS, Zabala JA. Guías de práctica clínica de la Sociedad Española de Cardiología en las cardiopatías congénitas más frecuentes. Rev Esp Cardiol. 2001; 54: 67-82.
  28. Ping T, Jerome K. The pulmonary vascular bed in children with Down syndrome. J Pediatr 1975 ; 86: 533-538. PubMed: https://pubmed.ncbi.nlm.nih.gov/123955/
  29. Guía JM, Bosch V, Castro FJ, Téllez C, Mercader B, et al. Factores influyentes en la evolución de la mortalidad de las cardiopatías congénitas. Estudio sobre 1216 niños en la Comunidad Autónoma de Murcia (1978-1990). Rev Esp Cardiol. 2001; 54: 299-306.
  30. Onalo R, Babaniyi IB. Congenital cardiac defectds in children with Down syndrome as seen in the University of Abuja Teaching Hospital, Gwagwalada, Abuja. New Niger J Clin Res. 2014; 4: 528–532.


Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?